News
Patient Frank Pattison talks about his experience - Channel 9 News
Listen to what Frank and his daughter have to say about the wonderful results achieved with the Rhenium-SCT on a Basel-Cell-Carcinoma on his ear.
Rhenium-SCT Rostock Trial results to be presented at EANM
This year the last patient in the Rhenium-SCT Rostock Trial had his final, 12 month follow up visit at the University Clinic in Rostock
The team from…
German skin cancer patients join the EPIC-Skin study
Garching, Munich. Germany – OncoBeta® GmbH has announced University Clinic of Rostock (is particpating in the global phase IV EPIC-Skin Study (Effic…
Interview with Dr. Joe Cardaci: committee member of the international Registry
Dr. Joe Cardaci, committee member of the international Registry, tells us a bit about his experience with the Rhenium-SCT and this world-first…
Rhenium-SCT reached Canadian medical news in LePatient
The non-invasive, single-session treatment for non-melanoma skin cancer, Rhenium-SCT, reached Canadian medical news. Le Patient, distributed by the…
Perth skin cancer patients undergo first treatments with OncoBeta’s Rhenium-SCT as part of the EPIC-Skin study
Perth, Australia– OncoBeta® GmbH today announced Perth’s Hollywood Private Hospital in Australia is the latest medical facility to participate in the…
Sydney skin cancer patients join the EPIC-Skin study as they undergo first treatments with OncoBeta’s Rhenium-SCT
Garching, Munich. Germany – OncoBeta® GmbH has announced its first Sydney-based patients were treated with Rhenium-SCT® as part of the global phase IV…
Sydney skin cancer patients join the EPIC-Skin study as they undergo first treatments with OncoBeta's Rhenium-SCT
Garching, Munich. Germany – OncoBeta® GmbH has announced its first Sydney-based patients were treated with Rhenium-SCT® as part of the global phase IV…
EPIC-Skin study welcomes world-first skin cancer patients treated with OncoBeta’s Rhenium-SCT
Garching,Munich.Germany – OncoBeta® GmbH has today announced a world-first from Australia, with the first patients treated with Rhenium-SCT® as part…
EPIC-Skin study welcomes world-first skin cancer patients treated with OncoBeta’s Rhenium-SCT
Garching,Munich.Germany – OncoBeta® GmbH has today announced a world-first from Australia, with the first patients treated with Rhenium-SCT® as part…